|
End-of-day quote
NYSE
|
||
| - USD | - |
|
| 07/17/07 | Allergan : Mylan defends chairman to ISS ahead of June 22 investor vote | RE |
| 02/17/02 | Allergan : U.S. state, local government lawsuits over opioids face uphill battle | RE |
| Manager | Title | Age | Since |
|---|---|---|---|
Scott Reents
PSD | President | 59 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Scott Reents
BRD | Director/Board Member | 59 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.04% | -1.40% | +57.16% | +108.15% | 1,03400Cr | |
| +1.17% | +4.76% | +56.42% | +73.50% | 67TCr | |
| -0.58% | +0.80% | +22.82% | +75.58% | 46TCr | |
| -0.13% | -0.45% | +29.52% | +38.60% | 35TCr | |
| -1.04% | +5.50% | +25.62% | +46.62% | 31TCr | |
| +0.15% | +1.80% | -0.02% | +13.99% | 26TCr | |
| +0.29% | +1.63% | +56.46% | +73.00% | 24TCr | |
| -0.41% | +2.10% | -16.31% | -53.97% | 21TCr | |
| +1.08% | +1.59% | +33.83% | +97.29% | 19TCr | |
| Average | -0.00% | +1.27% | +29.50% | +52.53% | 41.3TCr | |
| Weighted average by Cap. | -0.06% | +1.04% | +38.29% | +67.81% |
- Stock Market
- Stocks
- Stock
Select your edition
All financial news and data tailored to specific country editions
